Eli Lilly and Co is a globally active company in the healthcare sector. Its business model focuses on developing, manufacturing, and marketing innovative drugs and healthcare products to have positive impacts on people's lives.
The company operates in three main business areas: human pharmaceuticals, animal health, and biotechnology. In the field of human pharmaceuticals, the company offers a wide range of drugs for the treatment of diseases such as diabetes, cancer, arthritis, neurology, and more. Some of its well-known products include Humalog, Trulicity, Taltz, Jardiance, Forteo, and Alimta.
Eli Lilly and Co is also a major player in the animal health sector, providing veterinarians and pet owners with a wide range of drugs and services. This includes specialized products for the treatment of dogs, cats, horses, cattle, pigs, and poultry.
Through its biotechnology business areas, Eli Lilly and Co is also dedicated to the development of innovative therapies and technologies. It focuses on autoimmune diseases, pain management, cancer research, and affordable healthcare in emerging markets.
To ensure the success of its business model, Eli Lilly and Co invests billions annually in research and development of new drugs and healthcare solutions. A significant portion of these funds goes into clinical trials to ensure the safety and efficacy of the drugs.
Eli Lilly and Co intends to further expand its business by focusing on partnerships, mergers, and acquisitions to expand its portfolio and capabilities. In this context, the company has recently undertaken a number of acquisitions and partnerships, including Loxo Oncology, ImClone Systems, Sitryx, Armo BioSciences, and AC Immune.
Eli Lilly and Co generates revenue worldwide by selling its products directly to retailers, collaborating closely with doctors and other medical professionals, and selling its products to wholesalers and pharmacies. The company also operates its own facilities to provide medical services and products to people and pets.
In summary, Eli Lilly and Co is a leading company in the healthcare sector that aims to provide innovative and life-changing solutions for patients and pets worldwide. Through research, development, and strategic partnerships, the company has built a wide range of products and extensive expertise to effectively serve its customers and expand its presence in the global healthcare market.